ABX

Abacus Global Management

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Financial Services

industry

Insurance - Life

Exchange

NYSE

County of HQ

United States

Next Earnings Date

05/14/26

Business Summary

Abacus Global Management operates in the life insurance space, generating cash through underwriting risk, managing policy liabilities, and investing premium float. The core economic engine depends on accurately pricing mortality risk and earning spreads between investment returns and policy obligations. Scale, actuarial expertise, and disciplined asset-liability matching form the backbone of its competitive positioning. The moat is not brand-driven; it is balance-sheet driven — success hinges on underwriting precision, capital allocation discipline, and the ability to generate consistent returns on invested float.

VALUATION

P/E

22.6

Market Cap ($M USD)

$783

Forward P/E

7.3

PEG

-

PRICE TO SALES

3.4

PRICE TO BOOK

1.9

EV / EBITDA

10.5

5-Year Average P/E

DIVIDEND

Yield

2.50%

Annual Payout

$0.20

Payout Ratio

52.60%

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

$0.38

Next Year EPS Growth Estimate

$1.12

Next Year Revenue Growth Estimate

16.40%

Return on Equity (ROE)

8.70%

Operating Margin

36.30%

Debt-to-Equity

1

Piotroski F-Score

3

Altman Z-Score

-

Return on Invested Capital (ROIC)

7.50%%

Current Ratio

0.5

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At 22.6x earnings with a forward P/E of just 7.3, the market is pricing in a dramatic earnings reset, which is reinforced by the collapse from $10.5 in EPS to an estimated $0.38 next year. This is not a growth multiple — it is a compression story. A 3.4x Price/Sales and 1.9x Price/Book suggest the market is neither deeply distressed nor fully confident, placing the stock in a valuation limbo. With a 16.40% ROE but only a 7.50% ROIC, returns are acceptable yet not elite, and the weak 0.5 current ratio raises liquidity concerns. The stock is not obviously mispriced — it is priced for earnings instability and balance sheet tightness.

AI Exposure / Tech Reliance

As a life insurance company, ABX operates in a data-heavy, actuarial-driven industry where AI can materially enhance underwriting precision, claims automation, and risk modeling. The sector benefits from predictive analytics and mortality modeling improvements, which can support margin expansion beyond the current 8.70% operating margin. However, AI is an efficiency enhancer here, not a revenue revolution, meaning technology adoption will defend margins more than create explosive growth.

The Bull Case

A GARP investor could argue the forward P/E of 7.3 is the headline opportunity — the market is discounting future earnings aggressively relative to today’s 22.6 P/E, creating asymmetry if earnings stabilize above the $0.38 estimate. A 16.40% ROE in financial services is respectable, especially paired with a manageable 36.30% debt-to-equity ratio, which is not excessive for an insurance balance sheet. The 7.50% ROIC, while not spectacular, exceeds many capital-intensive financial peers and signals some underwriting discipline. Despite a weak Piotroski F-Score of 3, the company maintains profitability and pays a 2.50% dividend yield with a low 0.20 payout ratio, leaving room for capital retention. For a $783M market cap insurer, this is a small-cap value setup where even modest operational improvement could re-rate the multiple.

The Bear Case

The red flags are serious. EPS collapsing from $10.5 to an estimated $0.38 implies either a one-time distortion or a severe earnings contraction — and the market clearly expects pain. A Piotroski F-Score of 3 signals deteriorating fundamentals, while a 0.5 current ratio highlights potential liquidity stress in a business where balance sheet strength is paramount. The absence of a PEG ratio and Short % of Float removes visibility into growth-adjusted valuation and sentiment, but the mismatch between current EPS and forward estimates alone suggests earnings quality risk. Add in modest 8.70% operating margins and the stock starts to look less like deep value and more like a potential value trap.

Market Sentiment & Smart Money

Short Interest %

49.20%

Analyst Consensus

1.57

Average Analyst Price Target

$13.33

Institutional Ownership %

29.70%

1-Year Beta

1.07

Insider Buying % (6 Mo)

64.20%%

Distance to 52-Week High

77.10%%

Distance to 52-Week Low

176.50%%